Journal of Cardiac Failure

Editor's Page: The Future of the Journal of Cardiac Failure: A Reinvigorated Focus on People, Partnerships and Presentation. @dranulala @robmentz onlinejcf.com/article/S1071-…

I had to miss #HFA2025 in Belgrade to be home with kiddos. Luckily @JCardFail has got me covered with the #ICYMI series recapping all things #FunctionNotFailure Out now! Thank you @jozinetm @grote85532 & team for leading this 🔥 summary!!! onlinejcf.com/article/S1071-…

New month, new issue! Explore the latest research, reviews, and insights shaping the future of heart failure care in #JCF's May Issue. 🫀 Start reading: bit.ly/3CABnpt

Is iron deficiency anemia associated w/ exercise capacity in patients with LVADs? 🏃 Check out a quick take by @dranulala on a new JCF Brief Report exploring the link between iron deficiency anemia and pVO₂ on CPET. Dive deeper into the study here: bit.ly/4l0XXJe

Call for Papers: Focus Issue: Infiltrative & Inflammatory Cardiomyopathies Guest Editors Drs. Nisha Gilotra, Mat Maurer, and Emer Joyce will oversee this issue, publishing Winter 2026. Paper Categories & Topic Areas: bit.ly/46gZVRq 📆 Deadline: Oct 6, 2025

Iron deficiency anemia is associated with ⬇️ pVO2 in HF. But what does it look like in patients with LVADs? 🤔 This brief report shows a linear association between TSAT and pVO2 in pts with LVADs ❤️‍🩹🩸 🔗bit.ly/4l0XXJe

🚨New analysis of ICM vs NICM in HF-CS using CCC-TN registry. ICM associated with: ⬆️comorbidities, pre-admission cardiac arrests ⬆️ RRT, ventilation ⬇️ transplant, similar LVAD rates ⬆️ Mortality 💡Etiology matters—even with similar MCS & inotropes 🔗 bit.ly/4enuQgU

🔥 New JCF Ignite! 🚨 The Emerging Myth of PGD! 📌 Should the term Primary Graft Dysfunction give way to "Primary Graft Recovery"? 📌Bart et al propose a new definition of PGD for this new era of advanced organ preservation techniques. Learn more👇 🔗bit.ly/4nhs8O9

Do warmer 🔥☀️ temperatures ⬆️ risk of driveline infections?🚨 📌DLIs affect 40% of LVAD pts at 5 years 📌DLIs ⬆️mortality ⬆️ pump thrombosis & stroke, so prevention is 🔑 📌Calì et al found ⬆️ temperature = ⬆️ risk of DLIs Read more👇 🔗 bit.ly/4k7k2of

PROs provide valuable insight into pts health status, but can they be used to improve risk prediction in HF? 💡In this study, adding PROs to risk models improved ability to predict adverse events. How does your HF program utilize PRO assessments? 🔗 bit.ly/3FjX9j6

Still thinking about submitting? Time is running out.⏳ There are only a few days left to submit your work to the Journal of Cardiac Failure Hemodynamics Focus Issue. Make your research count. Deadline is June 30th. 🫀bit.ly/4lhroHr #HeartFailure #MedicalJournal

ICYMI: The 2024 Impact Factor released last week - we’re thrilled to say that JCF received 8.2, up from 6.7 in 2023. ❤️‍🔥 To us, impact is creating a community that moves the field forward, educating patients and colleagues, & amplifying voices from all corners of cardiology. 🌎

You’ve still got time - but not much! There are 2 weeks left to be part of the Journal of Cardiac Failure Hemodynamics Focus Issue. 🫀 If you're working in this space, we want to hear from you. 🔗www2.cloud.editorialmanager.com/cardfail/defau… #JCFImpact #AcademicPublishing

People. Experience. Community. Since 2020, it's been how we measure impact at JCF. When numbers reflect our mission, it's even sweeter 💜 🎉 JCF’s 2024 Impact Factor is ⬆️ 8.2 (from 6.7 in 2023) 🫀 Watch how we’re making a difference ⬇️ @Hfsa @robmentz @dranulala

📖 The June issue is here! Catch up on the latest in heart failure research, reviews & more from the Journal of Cardiac Failure. 🔗 onlinejcf.com/current #HeartFailure #Cardiology #JCF

Calling all authors! ✍️ There are only 4 weeks left to submit your work for the #JCF Hemodynamics Focus Issue. If your research advances the science of hemodynamics in heart failure, we want to hear from you. Submit your paper today: www2.cloud.editorialmanager.com/cardfail/defau…

A secondary analysis of the FINEARTS-HF trial examined the effect of finerenone vs. placebo on early readmissions in those randomized during/within 7 days of HHF. It showed that finerenone appeared to favorably influence risk of early HF readmissions. 🔗bit.ly/45pd2PM

To study HF RPM programs, a multinat'l (USA & India) single-arm trial of pts discharged following HHF was conducted. It showed that RPM ⬆️ NT-proBNP, KCCQ, 6MWT & GDMT utilization. This suggests a pathway to bridge the gap in post-HHF GDMT utilization. 🔗 bit.ly/4jdCMlM

Is uptitration of ARNI in stabilized hospitalized HF pts beneficial? Uptitration Rx led to greater ⬇️ NT-proBNP compared to ARNI w/o uptitration or ACEI/ARB after 8 weeks. In LVEF <40%, ARNI w/wo uptitration led to similar ⬇️ in NT-proBNP. 🔗bit.ly/3YPyHNe

Steroidal & non-steroidal MRA & aldosterone synthase inhibitors (ASi) are clinically available & being tested in trials. This review evaluates the similarities/differences between these agents & advocates for head-to-head comparisons to guide clinicians. bit.ly/4k0Hd4D

⏳ Time is running out to apply for the JCF 2025–26 Reviewer Mentorship Program! Open to early career clinicians in all specialties, including international applicants. Don't miss out! Applications due by tomorrow May 16th - no exceptions. 🔗 hfsa.org/jcf-reviewer-m…